99% Savings - Buy Just @1 Rs X
Monocef O CV 100/62.5 Dry Syrup 30ml is a prescription medicine that is available as a Syrup. Secondary and off-label uses of Monocef O CV 100/62.5 Dry Syrup 30ml have also been mentioned below.
The correct dosage of Monocef O CV 100/62.5 Dry Syrup 30ml depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Monocef O CV 100/62.5 Dry Syrup 30ml can also lead to other problems, which have been listed below. Normally, these side effects of Monocef O CV 100/62.5 Dry Syrup 30ml are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Monocef O CV 100/62.5 Dry Syrup 30ml's effect is Mild during pregnancy and Moderate for lactating mothers. It is important to know if Monocef O CV 100/62.5 Dry Syrup 30ml has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Monocef O CV 100/62.5 Dry Syrup 30ml related warnings section.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Monocef O CV 100/62.5 Dry Syrup 30ml since this can cause severe adverse effects. Other contraindications of Monocef O CV 100/62.5 Dry Syrup 30ml have been discussed in the sections ahead.
Drug reaction of Monocef O CV 100/62.5 Dry Syrup 30ml with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Monocef O CV 100/62.5 Dry Syrup 30ml, it is important to know that it is safe while driving, and is habit-forming.
Monocef O CV 100/62.5 Dry Syrup 30ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Monocef O CV 100/62.5 Dry Syrup 30ml safe for pregnant women?
Pregnant women can consume [medicine]. Though Monocef O CV has mild side effects when taken during pregnany
Is the use of Monocef O CV 100/62.5 Dry Syrup 30ml safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Monocef O CV. Immediately discontinue Monocef O CV if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Monocef O CV 100/62.5 Dry Syrup 30ml on the Kidneys?
Kidney can be affected by Monocef O CV. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Monocef O CV 100/62.5 Dry Syrup 30ml on the Liver?
You may experience side effects on your liver after taking Monocef O CV. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Monocef O CV 100/62.5 Dry Syrup 30ml on the Heart?
Side effects of Monocef O CV rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Monocef O CV 100/62.5 Dry Syrup 30ml unless your doctor advises you to do so -
Is this Monocef O CV 100/62.5 Dry Syrup 30ml habit forming or addictive?
Monocef O CV 100/62.5 Dry Syrup 30ml does not cause addiction.
Interaction between Food and Monocef O CV 100/62.5 Dry Syrup 30ml
Taking Monocef O CV 100/62.5 Dry Syrup 30ml with food does not cause any problems.
Interaction between Alcohol and Monocef O CV 100/62.5 Dry Syrup 30ml
It is difficult to say anything about the effect of Monocef O CV 100/62.5 Dry Syrup 30ml and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311